Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: An individual patient data meta-analysis

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Abdulla, Salim ^a   Ashley, Elizabeth A ^b,c   Bassat, Quique ^d,e   Bethell, Delia ^f   Björkman, Anders ^g   Borrmann, Steffen ^h,i   D’Alessandro, Umberto ^j,k   Dahal, Prabin ^b,l   Day, Nicholas P ^b,c   Diakite, Mahamadou ^m   Djimde, Abdoulaye A ^m   Dondorp, Arjen M ^b,c   Duong, Socheat ⁿ   Edstein, Michael D ^o   Fairhurst, Rick M ^p   Abul Faiz, M ^q   Falade, Catherine ^r   Flegg, Jennifer A ^s   Fogg, Carole ^t   Gonzalez, Raquel ^d,e   Greenwood, Brian ^u   Guérin, Philippe J ^b,l   Guthmann, Jean Paul ^v   Hamed, Kamal ^w   Tinh Hien, Tran ^b,x   Htut, Ye ^y   Juma, Elizabeth ^h   Lim, Pharath ^n,p   Mårtensson, Andreas ^g,z,aa   Mayxay, Mayfong ^b,ab,ac   Mokuolu, Olugbenga A ^ad   Moreira, Clarissa ^b,l   Newton, Paul ^b,ab   Noedl, Harald ^ae   Nosten, Francois ^b,af   Ogutu, Bernhards R ^h   Onyamboko, Marie A ^b,ag   Owusu Agyei, Seth ^ah   Pyae Phyo, Aung ^af   Premji, Zul ^ai   Price, Ric N ^b,l,aj   Pukrittayakamee, Sasithon ^c   Ramharter, Michael ^ak,al,am   Sagara, Issaka ^an   Se, Youry ^ao   Suon, Seila ⁿ   Stepniewska, Kasia ^b,l   Ward, Stephen A ^ap   White, Nicholas J ^b,c   Winstanley, Peter A ^aq   more..

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Manhiça Health Research Center   (Mozambique)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^f ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^g KAROLINSKA INSTITUTE   (Sweden)

^h KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

ⁱ Magdeburg University School of Medicine   (Germany)

^j INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^k Medical Research Council Unit   (Gambia)

^l WorldWide Antimalarial Resistance Network   (United Kingdom)

^m UNIVERSITY OF BAMAKO   (Mali)

ⁿ National Center for Parasitology Entomology and Malaria Control   (Cambodia)

^o AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^p NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^q Malaria Research Group and Dev Care Foundation   (Bangladesh)

^r UNIVERSITY OF IBADAN   (Nigeria)

^s MONASH UNIVERSITY   (Australia)

^t UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^u LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^v EPICENTRE   (France)

^w NOVARTIS PHARMA AG   (Switzerland)

^x OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^y Wellcome Trust Major Overseas Programme ^*  (Myanmar)

^z Malaria Research   (Sweden)

^aa UPPSALA UNIVERSITY   (Sweden)

^ab MAHOSOT HOSPITAL   (Laos)

^ac UNIVERSITY OF HEALTH SCIENCES   (Laos)

^ad UNIVERSITY OF ILORIN   (Nigeria)

^ae MEDICAL UNIVERSITY OF VIENNA   (Austria)

^af SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^ag Kinshasa School of Public Health   (Democratic Republic Congo)

^ah KINTAMPO HEALTH RESEARCH CENTRE   (Ghana)

^ai MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^aj MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^ak MEDICAL UNIVERSITY OF VIENNA   (Austria)

^al UNIVERSITY OF TÜBINGEN   (Germany)

^am Centre de Recherches Médicales de Lambaréné HÔpital Albert Schweitzer   (Gabon)

^an UNIVERSITY OF BAMAKO   (Mali)

^ao Armed Forces Research Institute of Medical Sciences   (Cambodia)

^ap LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^aq UNIVERSITY OF WARWICK   (United Kingdom)

more..

Author keywords

Artemisinin resistance; Drug resistance; Malaria; Parasite clearance; Plasmodium falciparum

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS CHLORPROGUANIL PLUS DAPSONE; ARTESUNATE PLUS MEFLOQUINE; CLINDAMYCIN; DIHYDROARTEMISININ PLUS PIPERAQUINE; DOXYCYCLINE; ANTIMALARIAL AGENT; ARTEMISININ;

AGE; ANEMIA; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CAMBODIA; DRUG TREATMENT FAILURE; FEVER; HUMAN; MALARIA FALCIPARUM; META ANALYSIS; MONOTHERAPY; MYANMAR; PARASITE CLEARANCE; PARASITEMIA; THAILAND; VIET NAM; ADOLESCENT; ADULT; AGED; ANIMAL; BLOOD; CHILD; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; DRUG RESISTANCE; FEMALE; INFANT; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIMALARIALS; ARTEMISININS; BLOOD; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITEMIA; PLASMODIUM FALCIPARUM; YOUNG ADULT;

EID: 84942511604     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0874-1     Document Type: Article

References (51)

1. White NJ. The parasite clearance curve. Malar J. 2011;10:278.
2. Tran TH, Day NP, Nguyen HP, Nguyen TH, Pham PL, Dinh XS, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med. 1996;335:76-83.
3. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67.
4. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50-5.
5. Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci USA. 2013;110:240-5.
6. Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies. Lancet Infect Dis. 2013;13:1043-9.
7. Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011;10:339.
8. Parasite Clearance Estimator [ http://www.wwarn.org/tools-resources/toolkit/analyse/parasite-clearance-estimator-pce ]. Accessed 8 Sept 2015.
9. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012;12:851-8.
10. Das D, Tripura R, Phyo AP, Lwin KM, Tarning J, Lee SJ, et al. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria. Clin Infect Dis. 2013;56:e48-58.
11. Hien TT, Thuy-Nhien NT, Phu NH, Boni MF, Thanh NV, Nha-Ca NT, et al. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J. 2012;11:355.
12. Lopera-Mesa TM, Doumbia S, Chiang S, Zeituni AE, Konate DS, Doumbouya M, et al. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. J Infect Dis. 2013;207:1655-63.
13. Mayxay M, Khanthavong M, Chanthongthip O, Imwong M, Lee SJ, Stepniewska K, et al. No evidence for spread of Plasmodium falciparum artemisinin resistance to Savannakhet Province, Southern Laos. Am J Trop Med Hyg. 2012;86:403-8.
14. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960-6.
15. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
16. Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Lindegardh N, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One. 2013;8:e57689.
17. WWARN Study Groups [ http://www.wwarn.org/working-together/study-groups ]. Accessed 8 Sept 2015.
18. Flegg JA, Guérin PJ, Nosten F, Ashley EA, Phyo AP, Dondorp AM, et al. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives. Malar J. 2013;12:411.
19. WWARN Parasite Clearance Study Group [ http://www.wwarn.org/working-together/study-groups/parasite-clearance-study-group ]. Accessed 8 Sept 2015.
20. Clinical Module: Data management and Statistical analysis Plan. Version 1.2. [ http://www.wwarn.org/sites/default/files/ClinicalDMSAP.pdf ]. Accessed 8 Sept 2015.
21. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, et al. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J. 2011;10:378.
22. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. [ http://www.who.int/vmnis/indicators/haemoglobin.pdf ]. Accessed 8 Sept 2015.
23. Lee SJ, Stepniewska K, Anstey N, Ashley E, Barnes K, Binh TQ, et al. The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J. 2008;7:149.
24. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Heal Organ; 2006. p. 312.
25. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619-20.
26. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, et al. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS One. 2011;6:e19283.
27. World Malaria Report 2013. World Health Organization. 2013.
28. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, et al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis. 2010;51:e82-9.
29. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-58.
30. WHO. Methods for surveillance of antimalarial drug efficacy. 2009. [ http://whqlibdoc.who.int/publications/2009/9789241597531-eng.pdf ]. Accessed 8 Sept 2015.
31. Glidden DV, Vittinghoff E. Modelling clustered survival data from multicentre clinical trials. Stat Med. 2004;23:369-88.
32. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-41.
33. Abdulla S, Sagara I, Borrmann S, D'Alessandro U, González R, Hamel M, et al. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet. 2008;372:1819-27.
34. Bouyou-Akotet MK, Ramharter M, Ngoungou EB, Mamfoumbi MM, Mihindou MP, Missinou MA, et al. Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon. Wien Klin Wochenschr. 2010;122:173-8.
35. Falade C, Makanga M, Premji Z, Ortmann C-E, Stockmeyer M, de Palacios PI. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 2005;99:459-67.
36. Fogg C, Twesigye R, Batwala V, Piola P, Nabasumba C, Kiguli J, et al. Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria. Trans R Soc Trop Med Hyg. 2008;102:25-31.
37. Hietala SF, Mårtensson A, Ngasala B, Dahlström S, Lindegårdh N, Annerberg A, et al. Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania. Antimicrob Agents Chemother. 2010;54:4780-8.
38. Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg. 2001;64:247-56.
39. Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, et al. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg. 2012;87:23-8.
40. Premji Z, Umeh RE, Owusu-Agyei S, Esamai F, Ezedinachi EU, Oguche S, et al. Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria. PLoS One. 2009;4:e6682.
41. Thanh NX, Trung TN, Phong NC, Quang HH, Dai B, Shanks GD, et al. The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam. Malar J. 2012;11:217.
42. Vugt MV, Wilairatana P, Gemperli B, Gathmann I, Phaipun L, Brockman A, et al. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg. 1999;60:936-42.
43. Starzengruber P, Swoboda P, Fuehrer H-P, Khan WA, Hofecker V, Siedl A, et al. Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in Bangladesh. PLoS One. 2012;7:e52236.
44. WorldWide Antimalarial Resistance Network. [ http://www.wwarn.org/ ]. Accessed 8 Sept 2015.
45. Chotivanich K, Tripura R, Das D, Yi P, Day NPJ, Pukrittayakamee S, et al. Laboratory detection of artemisinin-resistant Plasmodium falciparum. Antimicrob Agents Chemother. 2014;58:3157-61.
46. Suputtamongkol Y, Newton PN, Angus B, Teja-Isavadharm P, Keeratithakul D, Rasameesoraj M, et al. A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria. Br J Clin Pharmacol. 2001;52:655-61.
47. Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, et al. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2014;13:32.
48. Das D, Price RN, Bethell D, Guérin PJ, Stepniewska K. Early parasitological response following artemisinin-containing regimens: a critical review of the literature. Malar J. 2013;12:125.
49. Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, et al. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS One. 2011;6:e26005.
50. Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol. 1989;77:361-6.
51. Udomsangpetch R, Pipitaporn B, Silamut K, Pinches R, Kyes S, Looareesuwan S, et al. Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci USA. 2002;99:11825-9.